Morphological analogies of fetal prostate stroma and stromal nodules in BPH
- PMID: 9180933
- DOI: 10.1002/(sici)1097-0045(19970601)31:4<234::aid-pros4>3.0.co;2-k
Morphological analogies of fetal prostate stroma and stromal nodules in BPH
Abstract
Background: A "reawakening" of ontogenetic processes in the development of BPH is still in debate. Therefore, morphological analogies of fetal prostate stroma and nodular stromal proliferates in BPH were investigated.
Methods: Fetal prostates (n = 30; weeks 12-40 of gestation) and stromal nodules of benign prostatic hyperplasia (n = 375 from autopsies, n = 100 from biopsies) were investigated by histo- and immunohistochemistry with special regard to cytoskeletal (alpha-actin, desmin, myosin, and vimentin), neuronal (S-100 protein), neuroendocrine (neuron-specific enolase), leukocytic (CD3, CD20, and CD68) and vascular (CD34, BMA-120, and factor VIII) antigens.
Results: The developing fetal prostate stroma consists of immature mesenchymal cells up to week 17 of gestation, followed by fibroblastic and fibromuscular stromal cells up to week 25 of gestation and predominantly smooth-muscular cells until the end of gestation. Stromal nodules occur as immature mesenchymal, fibroblastic, fibromuscular, and smooth-muscular, suggestive of a maturational process. The fetal prostate stroma and the stromal nodules present, with an increasing degree of maturation, a similar vascular pattern and a similar occurrence of CD3 (T-lymphocytes), CD20 (B-lymphocytes), CD68 (macrophages), S-100, and neuron-specific enolase-positive cells.
Conclusions: The data suggest that ontogenetic processes are recapitulated in the development of stromal nodules in benign prostatic hyperplasia, supporting the idea of a "re-awakening" of fetal processes in BPH.
Similar articles
-
Stromal nodules in benign prostatic hyperplasia.Eur Urol. 1996;29(3):345-54. doi: 10.1159/000473774. Eur Urol. 1996. PMID: 8740022
-
[Morphological classification and comparison of the different types of stromal nodules in benign prostatic hyperplasia].Verh Dtsch Ges Pathol. 1993;77:111-6. Verh Dtsch Ges Pathol. 1993. PMID: 7511266 German.
-
[Early histopathological aspects of benign prostatic hyperplasia: myxoid-inflammatory nodules].Actas Urol Esp. 2010 Jun;34(6):549-54. Actas Urol Esp. 2010. PMID: 20510119 Spanish.
-
Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases.Am J Surg Pathol. 1998 Feb;22(2):148-62. doi: 10.1097/00000478-199802000-00002. Am J Surg Pathol. 1998. PMID: 9500215 Review.
-
Pathology of benign prostatic hyperplasia. Insight into etiology.Urol Clin North Am. 1990 Aug;17(3):477-86. Urol Clin North Am. 1990. PMID: 1695776 Review.
Cited by
-
The picture of the prostatic lymphokine network is becoming increasingly complex.Rev Urol. 2002 Fall;4(4):171-7. Rev Urol. 2002. PMID: 16985676 Free PMC article.
-
Progenitors in prostate development and disease.Dev Biol. 2021 May;473:50-58. doi: 10.1016/j.ydbio.2020.11.012. Epub 2021 Jan 30. Dev Biol. 2021. PMID: 33529704 Free PMC article. Review.
-
Cellular senescence as a possible link between prostate diseases of the ageing male.Nat Rev Urol. 2021 Oct;18(10):597-610. doi: 10.1038/s41585-021-00496-8. Epub 2021 Jul 22. Nat Rev Urol. 2021. PMID: 34294916 Review.
-
Growth factors in benign prostatic hyperplasia: basic science implications.Curr Urol Rep. 2008 Jul;9(4):272-8. doi: 10.1007/s11934-008-0048-6. Curr Urol Rep. 2008. PMID: 18765125 Review.
-
Stromal Androgen Receptor in Prostate Cancer Development and Progression.Cancers (Basel). 2017 Jan 22;9(1):10. doi: 10.3390/cancers9010010. Cancers (Basel). 2017. PMID: 28117763 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical